181 related articles for article (PubMed ID: 1985045)
1. Selective intestinal decontamination prevents spontaneous bacterial peritonitis.
Soriano G; Guarner C; Teixidó M; Such J; Barrios J; Enríquez J; Vilardell F
Gastroenterology; 1991 Feb; 100(2):477-81. PubMed ID: 1985045
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
3. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage.
Soriano G; Guarner C; Tomás A; Villanueva C; Torras X; González D; Sainz S; Anguera A; Cussó X; Balanzó J
Gastroenterology; 1992 Oct; 103(4):1267-72. PubMed ID: 1397884
[TBL] [Abstract][Full Text] [Related]
4. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
Llovet JM; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull MA; Rodés J
J Hepatol; 1997 Jan; 26(1):88-95. PubMed ID: 9148028
[TBL] [Abstract][Full Text] [Related]
6. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
Ginés P; Rimola A; Planas R; Vargas V; Marco F; Almela M; Forné M; Miranda ML; Llach J; Salmerón JM
Hepatology; 1990 Oct; 12(4 Pt 1):716-24. PubMed ID: 2210673
[TBL] [Abstract][Full Text] [Related]
7. [Variation of C3 in ascitic fluid from cirrhotic patients subjected to intestinal sterilization or selective intestinal decontamination].
Soriano G; Teixidó M; Guarner C; Such J; Espinós JC; Sainz S; Enríquez J; Rodríguez JL; Vilardell F
Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):123-6. PubMed ID: 2710995
[TBL] [Abstract][Full Text] [Related]
8. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Sandhu BS; Gupta R; Sharma J; Singh J; Murthy NS; Sarin SK
J Gastroenterol Hepatol; 2005 Apr; 20(4):599-605. PubMed ID: 15836710
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
[TBL] [Abstract][Full Text] [Related]
11. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
[TBL] [Abstract][Full Text] [Related]
12. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
13. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
Pande C; Kumar A; Sarin SK
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.
Assem M; Elsabaawy M; Abdelrashed M; Elemam S; Khodeer S; Hamed W; Abdelaziz A; El-Azab G
Hepatol Int; 2016 Mar; 10(2):377-85. PubMed ID: 26660707
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous bacterial peritonitis in cirrhotic patients: Is prophylactic propranolol therapy beneficial?
Cholongitas E; Papatheodoridis GV; Manesis EK; Burroughs AK; Archimandritis AJ
J Gastroenterol Hepatol; 2006 Mar; 21(3):581-7. PubMed ID: 16638103
[TBL] [Abstract][Full Text] [Related]
16. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
[TBL] [Abstract][Full Text] [Related]
17. Selective intestinal decontamination increases serum and ascitic fluid C3 levels in cirrhosis.
Such J; Guarner C; Soriano G; Teixidó M; Barrios J; Tena F; Méndez C; Enríquez J; Rodríguez JL; Vilardell F
Hepatology; 1990 Nov; 12(5):1175-8. PubMed ID: 2227816
[TBL] [Abstract][Full Text] [Related]
18. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
[TBL] [Abstract][Full Text] [Related]
19. Study on ascitic fluid protein level in cirrhotic patients with spontaneous bacterial peritonitis.
Mustafa MG; Al Mamun MA; Alam AK
Bangladesh Med Res Counc Bull; 2009 Aug; 35(2):41-3. PubMed ID: 20120777
[TBL] [Abstract][Full Text] [Related]
20. Bacterial DNA induces the complement system activation in serum and ascitic fluid from patients with advanced cirrhosis.
Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Márquez D; Santana F; Pérez-Mateo M; Such J
J Clin Immunol; 2007 Jul; 27(4):438-44. PubMed ID: 17404822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]